Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Bristol Myers Squibb

Bristol Myers Squibb

Rank: 7

2022 Rank: 9

New York, United States
www.bms.com

2022 Revenues ($USD) : $46,159,000,000.00
2022 R&D spend : $9,509,000,000.00
2022 Number of Employees : 34,300
Fiscal Year End : 12/31/22
Leader : CEO Dr. Giovanni Caforio

With its roots stretching back to the Squibb corporation founded in 1858, Bristol Myers Squibb now focuses on a range of therapeutic areas, including oncology, hematology, immunology, cardiovascular and fibrosis. In 2022, Bristol-Myers Squibb had a solid year, with sales reaching approximately $46 billion and a growth rate of 3%. The company's diversified product portfolio saw revenue growth of 13%, offsetting the loss of exclusivity for Revlimid (lenalidomide). With nine new product approvals and multiple indications, the company's new product portfolio could achieve $25 billion of non-risk-adjusted revenue by the decade's end. Full-year revenues exceeded $2 billion in 2022, nearly doubling over the prior year. The company had strong performance across various portfolios, including solid tumor, cardiovascular, hematology and immunology. —BB
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE